MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons

Synapse

Volumn 43, Issue 1, 2002, Pages 1-11

  Van De Witte, Serge V ^a   Groenewegen, Hendrik J ^a   Voorn, Pieter ^a,b  

^a Institute for Clinical and Experimental Neurosciences ICEN   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

6 Hydroxydopamine; Basal ganglia; Dynorphin; NMDA receptor; Substance P; Turning behavior

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DIZOCILPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DYNORPHIN; ENKEPHALIN; LEVODOPA; MESSENGER RNA; NEUROPEPTIDE; PREPRODYNORPHIN; PREPROENKEPHALIN; PREPROTACHYKININ; SUBSTANCE P;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DEPLETION; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOPAMINE AGENTS; DOPAMINE AGONISTS; DRUG INTERACTIONS; DYNORPHINS; DYSKINESIA, DRUG-INDUCED; ENKEPHALINS; EXCITATORY AMINO ACID ANTAGONISTS; IMMUNOHISTOCHEMISTRY; LEVODOPA; MALE; MOTOR ACTIVITY; NEOSTRIATUM; NEURONS; NEUROPEPTIDES; OXIDOPAMINE; PARKINSONIAN DISORDERS; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; TACHYKININS; TYROSINE 3-MONOOXYGENASE;

EID: 0036132578     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.1113     Document Type: Article

References (43)

1. The functional anatomy of basal ganglia disorders
2. Parallel organization of functionally segregated circuits linking basal ganglia and cortex
3. Basal gangliathalamocortical circuits: Parallel substrates for motor, oculomotor, 'prefrontal'; and 'limbic'; functions
4. Striatal fosB expression is causally linked with I-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease
5. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa
6. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin and glutamic acid decarboxylase mRNA
7. Sequence and expression of the rat prodynorphin gene
8. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs
9. Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum
10. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats
11. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis
12. Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion
13. The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: Evidence for a parallel organization
14. Chronic dizocilpine maleate (MK-801) treatment suppresses the effects of nigrostriatal dopamine deafferentation on enkephalin but not on substance P expression in the rat striatum
15. The kappaopioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat
16. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease
17. Effect of repeated LDOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat
18. Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism
19. Cocaine self-administration differentially alters mRNA expression of striatal peptides
20. Problems with current pharmacologic treatment of Parkinson's disease
21. Glutamatergic regulation of striatal peptide gene expression in rats
22. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
23. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A
24. Success and problems of long-term levodopa therapy in Parkinson's disease
25. The organization of the projection from the cerebral cortex to the striatum in the rat
26. Stereospecific blockade of N-methyl-Daspartate transmission by MK 801 prevents priming of SKF 38393-induced turning
27. Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses
28. Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen
29. A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease
30. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity
31. Priming of 6-hydroxydopamine-lesioned rats with L-DOPA or quinpirole results in an increase in dopamine D1 receptor-dependent cyclic AMP production in striatal tissue
32. Sensitization to the behavioral effects of cocaine: Modulation by dynorphin and kappa-opioid receptor agonists
33. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism
34. N-methyl-D-aspartate receptor antagonism alters substance P and met5-enkephalin biosynthesis in neurons of the rat striatum
35. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum
36. Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: Relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction
37. Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: Evidence for induction of FosB- and JunD-related proteins
38. Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist
39. Dynorphin modulates dopamine D1-receptor mediated turning behavior in 6-hydroxydopamine-lesioned rats
40. Rat brain preproenkephalin mRNA, cDNA cloning, primary structure, and distribution in the central nervous system
41. In situ hybridization histochemistry
42. Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat